Sutro Biopharma, Inc./$STRO
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Sutro Biopharma, Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
Ticker
$STRO
Sector
Primary listing
Employees
178
Headquarters
Website
STRO Metrics
BasicAdvanced
$74M
-
-$25.88
1.62
-
Price and volume
Market cap
$74M
Beta
1.62
52-week high
$9.38
52-week low
$7.15
Financial strength
Current ratio
2.533
Quick ratio
2.386
Long term debt to equity
-11.116
Total debt to equity
-20.238
Interest coverage (TTM)
-3.53%
Profitability
EBITDA (TTM)
-128.985
Gross margin (TTM)
136.66%
Net profit margin (TTM)
-205.18%
Operating margin (TTM)
-129.26%
Effective tax rate (TTM)
-1.09%
Revenue per employee (TTM)
$590,000
Management effectiveness
Return on assets (TTM)
-25.80%
Return on equity (TTM)
-1,810.01%
Valuation
Price to revenue (TTM)
0.687
Price to book
-0.84
Price to tangible book (TTM)
-0.84
Price to free cash flow (TTM)
-0.322
Free cash flow yield (TTM)
-310.31%
Free cash flow per share (TTM)
-26.872
Growth
Revenue change (TTM)
-34.36%
Earnings per share change (TTM)
49.14%
3-year revenue growth (CAGR)
14.82%
3-year earnings per share growth (CAGR)
0.36%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Sutro Biopharma, Inc. stock?
Sutro Biopharma, Inc. (STRO) has a market cap of $74M as of December 09, 2025.
What is the P/E ratio for Sutro Biopharma, Inc. stock?
The price to earnings (P/E) ratio for Sutro Biopharma, Inc. (STRO) stock is 0 as of December 09, 2025.
Does Sutro Biopharma, Inc. stock pay dividends?
No, Sutro Biopharma, Inc. (STRO) stock does not pay dividends to its shareholders as of December 09, 2025.
When is the next Sutro Biopharma, Inc. dividend payment date?
Sutro Biopharma, Inc. (STRO) stock does not pay dividends to its shareholders.
What is the beta indicator for Sutro Biopharma, Inc.?
Sutro Biopharma, Inc. (STRO) has a beta rating of 1.62. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.